By Thom King, CFS, Founder and Chief Innovation Officer, Icon Foods

Monk fruit has rapidly evolved from a niche specialty sweetener into a serious tool for modern sugar reduction. Its clean-label positioning, natural origin story, and favorable sweetness profile have made it increasingly attractive to food and beverage developers looking to reduce sugar without leaning on artificial sweeteners.

But regulatory acceptance of monk fruit varies dramatically across global markets.

In the United States, monk fruit extract enjoys broad commercial use under GRAS determinations. Canada remains substantially more restrictive. The European Union and United Kingdom sit somewhere in the middle, where the regulatory status depends heavily on the type of monk fruit ingredient being used and how that ingredient is processed.

For formulators, this distinction matters. A monk fruit system that works perfectly in the U.S. may hit a regulatory brick wall in Europe or require significant reformulation before commercialization.

The key issue is not simply whether monk fruit is permitted. The real question is:

What form of monk fruit is being used, how is it processed, and which regulatory body has reviewed it? That is where the entire game is played.

Understanding the Regulatory Distinction

The regulatory landscape surrounding monk fruit centers on a critical distinction between:

  1. Traditional-style monk fruit decoctions or juice concentrates
  2. Purified high-intensity monk fruit sweetener extracts

These are treated very differently by regulatory authorities.

Monk Fruit Decoctions

Monk fruit decoctions are generally non-selective aqueous extracts made from fresh or dried Siraitia grosvenorii fruit.

These preparations:

  • use water extraction,
  • do not selectively isolate mogrosides,
  • and more closely resemble traditional food preparations historically consumed in parts of Asia.

Because of this, regulators may view them more like conventional food ingredients.

Purified Monk Fruit Extracts

Purified monk fruit extracts are processed specifically to concentrate sweet mogrosides, particularly mogroside V. These ingredients include:

  • V25 monk fruit extract
  • V40 monk fruit extract
  • V50 monk fruit extract
  • high-purity mogroside systems
  • sweetness-optimized commercial extracts

Once the extraction process selectively concentrates mogrosides for sweetness functionality, regulators often shift classification toward:

  • food additive sweeteners,
  • novel food ingredients,
  • or regulated high-intensity sweeteners.

This distinction dramatically changes the regulatory pathway.

European Union Position

EU Novel Food Framework

The European Union regulates many emerging ingredients through the Novel Food Regulation framework.

Under EU law, foods or ingredients without significant documented consumption prior to May 15, 1997 may require authorization before commercialization.

Historically, purified monk fruit extracts faced regulatory uncertainty because:

  • monk fruit lacked broad historical consumption within the EU,
  • and purified mogroside systems were viewed as highly processed sweetener ingredients.

However, more recent evaluations have created important movement for traditional-style monk fruit ingredients.

Non-Selective Monk Fruit Decoctions

The Food Safety Authority of Ireland, operating within the EU consultation framework, determined that certain monk fruit decoctions are not considered novel foods when they are:

  • non-selective aqueous extracts,
  • derived from fresh or dried monk fruit,
  • and produced without selective concentration of mogrosides.

This determination significantly improves the commercial pathway for these types of monk fruit ingredients within the EU.

The ruling specifically applies to traditional-style water extracts rather than highly purified sweetener systems.

Purified Monk Fruit Extracts in the EU

Purified monk fruit extracts remain a more complex regulatory matter. Highly concentrated mogroside systems intended to function as high-intensity sweeteners may still require:

  • separate authorization,
  • safety review,
  • or additional regulatory assessment depending on the ingredient and application.

The European Food Safety Authority (EFSA) has previously reviewed monk fruit extract sweeteners and concluded that available data at the time were insufficient to establish safety under proposed conditions of use.

As a result, formulators should not assume that U.S.-style monk fruit sweetener systems automatically translate into EU compliance.

United Kingdom Position

UK Food Standards Agency Determination

The United Kingdom Food Standards Agency (FSA) has also evaluated monk fruit ingredients under its post-Brexit regulatory framework. In 2024, the FSA determined that:

  • non-selective aqueous decoctions of monk fruit,
  • produced from fresh or dried Siraitia grosvenorii,
  • are not considered novel foods in England and Wales.

This determination provides a clearer commercial pathway for traditional-style monk fruit ingredients in the UK market.

Important Regulatory Limitation

The FSA determination applies specifically to: non-selective aqueous decoctions.

It does not automatically authorize: purified monk fruit extracts, highly concentrated mogroside systems, or sweetness-optimized extracts functioning primarily as high-intensity sweeteners.

Those ingredients may still require additional authorization depending on:

  • concentration,
  • extraction process,
  • intended use,
  • and technical functionality.

For formulators, this distinction is critical. A monk fruit decoction and a V50 monk fruit extract may originate from the same fruit, but regulators may treat them like entirely different players on the field.

What Governing Bodies Actually Evaluate

Several regulatory authorities play major roles in determining whether monk fruit ingredients can be used as food ingredients or sweeteners.

European Food Safety Authority (EFSA)

EFSA evaluates:

  • ingredient safety,
  • exposure assessments,
  • toxicology,
  • and proposed use conditions within the EU.

EFSA’s conclusions heavily influence whether purified monk fruit ingredients can move forward under EU regulations.

Food Standards Agency (FSA) – United Kingdom

The UK FSA evaluates:

  • novel food status,
  • ingredient history of consumption,
  • extraction methodology,
  • and safety considerations within the UK market.

The FSA’s 2024 monk fruit decoction determination represents one of the most meaningful recent developments for monk fruit commercialization in Europe.

National Food Authorities Within the EU

Individual member-state authorities may also participate in:

  • consultation procedures,
  • historical consumption evaluations,
  • and interpretation of novel food status.

The Food Safety Authority of Ireland played a significant role in evaluating monk fruit decoctions within the EU consultation process.

Practical Implications for Formulators

U.S. Formulas Cannot Be Assumed Compliant

A formulation using:

  • V40,
  • V50,
  • or highly purified monk fruit extract

may not automatically be suitable for:

  • the EU,
  • the UK,
  • or Canada.

This creates challenges including:

  • reformulation,
  • dual inventory management,
  • relabeling,
  • separate sensory optimization,
  • and commercialization delays.

Ingredient Documentation Is Critical

Before launching products into Europe or the UK, formulators should verify:

  • extraction methodology,
  • mogroside concentration,
  • processing details,
  • technical function,
  • and supplier regulatory documentation.

The regulatory outcome may depend as much on how the ingredient is manufactured as on the ingredient itself.

Hybrid Sweetener Systems Become More Important

Because purified monk fruit extracts remain more restricted in certain jurisdictions, formulators often rely on broader sweetener architectures including:

  • steviol glycosides,
  • thaumatin,
  • fibers,
  • tagatose,
  • erythritol,
  • allulose where permitted,
  • and flavor modulators.

In many systems, monk fruit decoctions may serve as supporting components rather than primary sweeteners.

Sensory Expectations Must Be Adjusted

Traditional monk fruit decoctions generally do not deliver the same sweetness intensity as purified mogroside extracts. As a result, formulators may need to account for:

  • lower sweetness potency,
  • additional flavor contribution,
  • higher inclusion levels,
  • color impact,
  • and altered temporal sweetness performance.

That means formulation strategy becomes more nuanced and system-oriented rather than relying on a single high-intensity sweetener solution.

Future Outlook

The regulatory trajectory for monk fruit in Europe and the UK appears to be gradually evolving. Several market forces continue to push momentum forward:

  • consumer rejection of artificial sweeteners,
  • rapid growth of reduced-sugar products,
  • increasing demand for natural ingredients,
  • and advances in ingredient characterization and safety data.

Recent acceptance of non-selective monk fruit decoctions represents a meaningful shift toward broader market viability for certain monk fruit ingredient types.

However, purified mogroside-rich sweetener systems remain under greater regulatory scrutiny and should not be treated as universally approved across all markets.

Monk fruit continues to hold substantial promise as a natural sugar-reduction tool, particularly for clean-label food and beverage innovation.

Within the EU and UK, however, regulatory acceptance depends heavily on:

  • ingredient composition,
  • extraction methodology,
  • concentration,
  • and intended technical function.

Traditional-style monk fruit decoctions now have a clearer commercial pathway in both the EU and UK, while purified high-intensity monk fruit extracts remain more restricted and subject to additional regulatory evaluation.

For formulators, successful commercialization increasingly depends on understanding not only the ingredient itself, but also:

  • how regulators classify it,
  • how it is processed,
  • and how it functions within the finished product.

In sugar reduction, the science matters. In global commercialization, the regulatory fine print matters just as much.

References

  1. European Commission. Novel Food Consultation Outcome: Monk Fruit Decoctions.
    https://food.ec.europa.eu/document/download/cfdc21d5-8685-495e-916a-602edec16eaf_en
  2. Food Standards Agency (UK). Determination of Non-Selective Aqueous Decoctions of Monk Fruit.
    https://www.food.gov.uk/other/non-selective-aqueous-decoctions-of-monk-fruit-determination-of-the-status-of-a-novel-food-pursuant-to-article-42-of-assimilated
  3. European Food Safety Authority (EFSA). Safety Evaluation of Monk Fruit Extract as a Food Additive.
    https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2019.5921
  4. Monk Fruit Corp. UK FSA Monk Fruit Regulatory Announcement.
    https://monkfruitcorp.com/wp-content/uploads/FSA-Press-Release-20240627.-Final-Letterhead-1.pdf

Related reading: Monk Fruit in Canada, Allulose at the Border and Is Monk Fruit Sweetener Safe?.